Experiments show that transferring a cancer cell's dysfunctional mitochondria—but not its nucleus—into a healthy cell is what induces cancer. This disruptive finding supports the view of cancer as a metabolic disease that can be targeted by starving its mitochondria of fuels like glucose.

Many cancer cells rely heavily on glucose (the Warburg effect) and cannot efficiently use ketones. A strict ketogenic diet may starve these tumors while nourishing healthy cells. In one case, it led to a 70% reduction in cancer markers in six weeks, far exceeding chemotherapy's expected 30%.

Beyond being an alternative fuel source, the ketone body beta-hydroxybutyrate (BHB) functions as a signaling molecule. It acts as an HDAC inhibitor, which can activate genes that enhance the body's antioxidant and cellular defense mechanisms, a pathway of interest in cancer therapy.

Hyperbaric oxygen creates oxidative stress that healthy cells can manage but cancer cells with damaged mitochondria cannot. When combined with a ketogenic diet that already weakens the tumor, this therapy becomes a targeted weapon that selectively kills cancer cells while sparing healthy ones.

The spirochete that causes Lyme disease is highly dependent on glucose (glycolytic). A ketogenic diet restricts its primary fuel source while also stimulating the body's adaptive immune response, offering a two-pronged metabolic approach to managing the disease.

While many aim for the highest possible ketone readings, research indicates the therapeutic 'sweet spot' is 1-2 millimolar for most applications. Levels above this can cause 'reductive stress' and energy toxicity, which are counterproductive for general metabolic health.

In a ketogenic state, healthy cells enter a protective "bunker mode," slowing division. Cancer cells lack this evolutionary off-switch and remain exposed. This synergy makes tumors more vulnerable to chemotherapy, allowing for lower, less toxic doses with greater effect.

The origin of cancer is damage to the mitochondria, the cell's powerhouses. This impairs energy production, forcing cells into a primitive state of uncontrolled growth. Genetic mutations are a downstream effect, not the primary cause.

Mainstream oncologists often advise against keto diets, fearing they accelerate cachexia (severe wasting). This conflates pathological wasting, where the tumor devours muscle, with therapeutic weight loss from a state of ketosis, which actually starves the tumor.